Silica-coated papillomavirus-based nanoparticles: a shielded scaffold for HIV-1 vaccines
Abstract
, the silica coating effectively masked L1-specific B cell epitopes, reduced anti-scaffold IgG responses and enhanced Env-specific antibody production in mice pre-immunized against HPV. This synthetic strategy offers a versatile platform for overcoming scaffold-directed immunity in nanoparticle vaccines.
Fields of Study & Subjects
Immunotherapy and Immune Responses
Advanced Drug Delivery Systems
HIV Research and Treatment
Publication details
- Journal / source
- Biomaterials Science
- Publisher
- Royal Society of Chemistry (RSC)
- Volume
- 14
- Issue
- 12
- Pages
- 3281–3294
- Publication date
- 1 January 2026
- Language
- EN